Michigan State University physicians have found that vitamin D, if taken for at least three years, could help cancer patients live longer. The findings suggest that the vitamin carries significant benefits other than just contributing to healthy bones and were presented at the American Society of Clinical Oncology annual meeting on June 3, 2019. In
ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment of an advanced therapy medicinal product (ATMP) as part of the European Medicines Agency’s Priority Medicines (PRIME) program ZYNTEGLO is bluebird bio’s first gene therapy to gain regulatory approval bluebird bio, Inc. announced today that the European Commission (EC)
Source: Nature Study of almost half a million people links mutation that protects against HIV infection to an earlier death. The scientist who edited the genomes of twin girls in an attempt to make them resistant to HIV might have inadvertently shortened their life expectancy. People with two disabled copies of the CCR5 gene — the version
Scientists have successfully 3D printed a cornea utilizing a biocompatible bioink, composed of decellularized corneal stroma and stem cells, resulting in a replica with transparency similar to a human cornea. A collaborative team of engineering and medical scientists from the Pohang University of Science and Technology (Republic of Korea) have developed a strategy for 3D
Novel molecules developed by researchers at the Rockefeller University (NY, USA) have the potential to provide treatments for the millions of people who suffer from an autoimmune disorder. Reported recently in Nature Communications, Thomas Tuschl (Professor at Rockefeller University; NY, USA) and his fellow researchers from have developed small molecules that can bind to and inhibit one
While wrist-worn wearables accounted for the majority of the market with 63.2% share, ear-worn devices experienced the fastest growth (135.1% YoY). Global shipments of wearable devices reached 49.6 million units during the first quarter of 2019, up 55.2% from the previous year according to data from the International Data Corporation (IDC) Worldwide Quarterly Wearable Device
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer. Piqray is to be used in combination with the FDA-approved endocrine therapy, fulvestrant, to treat post-menopausal patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer (as detected by
Most antibiotics work by interfering with critical functions such as DNA replication or construction of the bacterial cell wall. However, these mechanisms represent only part of the full picture of how antibiotics act. For more information see the IDTechEx report on Digital Health 2019. In a new study of antibiotic action, MIT researchers developed
Artificial intelligence could revolutionize medical imaging, but how can stakeholders translate the technology from research to clinical practice? Countless studies have shown the many ways artificial intelligence could transform the medical imaging field. From detecting lung cancer as well as human radiologists to predicting kidney functionfrom renal biopsies, machine learning and deep learning algorithms have demonstrated their potential
The adoption of single-use devices in healthcare has contributed to an improved patient experience, lower readmittance rates, faster clinical trials, and a more educated patient base. But how do you go about adopting a single-use device into your product offering? This guide will introduce you to the key components that go into delivering a single-use mobile
